Within the research line “Platelet-based Therapeutic Applications”, we have identified the current limitations of platelet-rich bioproducts, and we have developed a novel method to obtain platelet secretomes:
Our technology allows the refined extraction of the growth factors and bioactive molecules stored in platelet granules, leaving out plasma, cells, and person-specific structural elements that could lead to adverse reactions. This allows us to create a highly enriched bioproduct that is effective for promoting proper tissue regeneration and provides significant competitive advantages from a therapeutic standpoint, which make it unique.
Competitive advantages
UNIVERSAL
No patients excluded
DELIVERY SYSTEMS
Encapsulated
Target release
Novel clinical applications
OFF-THE-SHELF
Ready-to-use
New formulations (gels, dressing, etc) & storage options (lyophilized)
Publications
Get to know the latest work from our team
